TET2 and acute myeloid leukemia: Accordingly, Delhommeau et al. reported that TET2 mutations are early events in patients with some MDS and secondary AML and confirmed the important role of TET2 in maintaining the balance between hematopoietic cell survival, growth and differentiation (38).